XRF Scientific (XRF) H2 2024 earnings summary

Executive summary

• Achieved record revenue of $60.1m, up 9% year-over-year, and NPAT of $9.5m, up 16% from FY23.

• All core divisions performed strongly, with international sales growth in Europe, Asia, and the Americas.

• Fully acquired Orbis Mining post year-end, expected to drive further growth.

• Declared a fully franked final dividend of 3.9 cents per share, up 18% from last year.

• Maintained a robust balance sheet with $12.0m cash and $1.6m debt at year-end.

Financial highlights

• Revenue: $60.1m (FY23: $55.3m), up 9% year-over-year.

• Net Profit After Tax: $9.5m (FY23: $8.2m), up 16% year-over-year.

• Basic and diluted EPS: 6.4 cents (FY23: 5.6 cents), up 15%.

• Operating cash flow: $8.1m, down 4% from FY23.

• Final dividend of 3.9 cents per share declared, fully franked.

Outlook and guidance

• Focus on geographic expansion and new product development to drive future growth.

• Ongoing evaluation of acquisition opportunities in adjacent sectors.

• Expectation of continued strong performance from Orbis Mining and new product launches in FY25.